A recent survey from the American Academy of Sleep Medicine highlights a surprising paradox: 81% of Americans report losing ...

New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...

Obese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic ...

Indiana’s Medicaid program estimates the Biden administration’s proposal to expand coverage of weight-loss treatment for ...

A new study found that getting eight hours of sleep a night can "significantly" improve the ability to learn a new language, ...

Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” third-quarter 2024 ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

A study on 120 people with insomnia found that the weighted blankets helped them sleep better compared to a light blanket.

Though past research has focused on the health benefits of cheese, the new data examined its direct relationship to the ...